HealthVerity at ISPOR 2025: Solving RWD Challenges in Pharma and HEOR
Thank you to everyone who joined us at ISPOR 2025 in Montreal. Whether you stopped by our booth,...
Understanding re-identification risk in PPRL: key takeaways from our expert webinar
New research is challenging long-held assumptions about privacy-preserving record linkage (PPRL). While PPRL remains essential for de-identified data exchange, the study presented during our recent webinar shows that certain token-based approaches...
HealthVerity data strengthens regulatory submissions and clinical trials
Why data provenance matters for regulatory submissions and clinical trials Regulators increasingly...
Curated data in life sciences: the cornerstone of research readiness and precision
This is part three of a three-part series on the essential qualities of claims data for life...
Consistent data in life sciences: the key to reliable, reproducible, and actionable research
This is part two of a three-part series (read part 1, part 3) on the essential qualities of claims...
The best closed claims data for RWE and HEOR — HealthVerity taXonomy
This is part one of a three-part series (read part 2, part 3) on the essential qualities of claims...
Verified Data: The foundation of trust in real-world evidence
The problem with Zombie Data—And the critical need for Verified Data In life sciences, where...
How to optimize real-world data with lab results for clinical trials & HEOR
Key benefits of real-world lab data for life sciences and pharma Real-world lab results enhance...
Zombie Data: The silent threat to real-world data in life sciences
In the rapidly evolving world of real-world data (RWD) for life sciences and commercial...
What’s Broken in Audience Targeting - And How to Fix It
The one constant in healthcare marketing is change, particularly in four key areas: Evolving...
Unlock open and closed claims data with taXOnomy: Claim better outreach
In the evolving world of real-world data (RWD), pharmaceutical companies are increasingly focused...